SEPTEMBER - 20201TECH OUTLOOKSeptember - 14 - 2020www.pharmatechoutlook.comTECH OUTLOOKA NEW PARADIGM IN IMMUNO-ONCOLOGY THERAPY MATT COFFEY, PRESIDENT & CEOIMMUNOTHERAPYEDITION$15ISSN 2644-2787
Page 2 >